Table 1. Correlation of the expression of WDFY4 in lung cancer with clinicopathologic features.
| Characteristics | No. of patients | WDFY4 | p-value | |
| High expression n (%) | Low expression n (%) | |||
| Overall | 98 | 10 (10.2) | 88 (89.8) | |
| Age | ||||
| <60 years, n (%) | 45 (45.9) | 5 (11.1) | 40 (88.9) | 0.3280 |
| ≥60 years, n (%) | 53 (54.1) | 5 (9.4) | 48 (90.6) | |
| Gender | ||||
| Female, n (%) | 39 (39.8) | 3 (7.7) | 36 (92.3) | 0.5042 |
| Male, n (%) | 59 (60.2) | 7 (74.6) | 52 (25.4) | |
| Tumor size | ||||
| <5.0 cm, n (%) | 72 (73.5) | 7 (9.7) | 65 (90.3) | 0.7931 |
| ≥5.0 cm, n (%) | 26 (26.5) | 3 (11.5) | 23 (88.5) | |
| Primary tumor location | ||||
| Left pulmonary, n (%) | 56 (57.1) | 9 (16.1) | 47 (83.9) | 0.0267 |
| Right pulmonary, n (%) | 42 (42.9) | 1 (2.4) | 41 (97.6) | |
| Pathological grade | ||||
| I + II, n (%) | 69 (70.4) | 3 (4.3) | 66 (95.7) | 0.6007 |
| III, n (%) | 29 (29.6) | 2 (6.9) | 27 (93.1) | |
| Lymph node metastasis | ||||
| Negative, n (%) | 52 (53.1) | 5 (9.6) | 47 (90.4) | 0.8378 |
| Positive, n (%) | 46 (46.9) | 5 (10.9) | 41 (89.1) | |
| TNM stage | ||||
| I + II, n (%) | 66 (67.3) | 5 (7.6) | 61 (92.4) | 0.217 |
| III + IV, n (%) | 32 (32.7) | 5 (15.6) | 27 (84.4) | |